Literature DB >> 31561349

Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.

J Schaible1, C Stroszczynski1, L P Beyer1, E M Jung1.   

Abstract

OBJECTIVE: The use of a standardized dynamic contrast enhanced ultrasound (CEUS) protocol to determine perfusion of hepatocellular carcinomas (HCC) using quantitative analysis.
METHODS: Retrospective analysis of 27 patients with hepatocellular carcinoma examined by a standardized protocol (bolus injection of 2.4 ml sulphur hexafluoride microbubbles, arterial phase to portal venous phase using continuous CINE-loops over 1 minute, short CINE-loops after 2, 3, 4, 5 and 6 minutes and additional single images for B-mode, CCDS). The examination was performed by an experienced sonographer with a high resolution, multi-frequency transducer (1-6 MHz). The reading of the reference imaging (contrast enhanced CT and MRI) and histopathology, if necessary, was performed independently. Retrospective analysis of the CEUS DICOM loops was done using time intensity curve analysis (TIC) with evaluation of the time to peak (TTP) and the area under the curve (AUC).
RESULTS: All tumor lesions were characterized by CEUS, based on typical contrast patterns for HCC lesions with arterial enhancement and wash out in the late phase, corresponding to MRI with liver specific contrast agent or contrast enhanced CT. Mean TTP (SD) in the tumor centre (C) was 19.93 (11.31), in the periphery (P) 22.94 (9.44) and in the normal liver tissue (LT) 28.19 (11.34) with significant differences between all zones C/P (p = 0.013), C/LT (p = 0.005) and P/LT (p = 0.022). AUC mean (SD) in the tumor centre (C) was 660.03 (292.64), in the periphery (P) 586.04 (237.01) and in the normal liver tissue (LT) 484.20 (236.99), also with significant differences between all zones C/P (p = 0.001), C/LT (p < 0.001) and P/LT (p < 0.001).
CONCLUSION: TIC-analysis is an easy-to-use tool for the dynamic evaluation of microvascularization in hepatocellular carcinoma and allows a fast and cost-efficient quantitative analysis.

Entities:  

Keywords:  CEUS; Contrast enhanced ultrasound; TIC-analysis; hepatocellular carcinoma; quantitative analysis

Mesh:

Substances:

Year:  2019        PMID: 31561349     DOI: 10.3233/CH-199221

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

1.  Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study.

Authors:  Yandong Jiang; Meng Zhang; Yanting Zhu; Dongxiao Zhu
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation-Results from a Prospective Single-Center Study.

Authors:  Antonio Tufano; Francesco Maria Drudi; Flavia Angelini; Eleonora Polito; Milvia Martino; Antonio Granata; Giovanni Battista Di Pierro; Eriselda Kutrolli; Matteo Sampalmieri; Vittorio Canale; Rocco Simone Flammia; Daniele Fresilli; Michele Bertolotto; Costantino Leonardo; Giorgio Franco; Vito Cantisani
Journal:  Diagnostics (Basel)       Date:  2022-05-12

3.  Deep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma.

Authors:  Yafang Zhang; Qingyue Wei; Yini Huang; Zhao Yao; Cuiju Yan; Xuebin Zou; Jing Han; Qing Li; Rushuang Mao; Ying Liao; Lan Cao; Min Lin; Xiaoshuang Zhou; Xiaofeng Tang; Yixin Hu; Lingling Li; Yuanyuan Wang; Jinhua Yu; Jianhua Zhou
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.